drugset
drugset / Trial / NCT02426632

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

NCT02426632 ↗

Phase 1 Completed 12 enrolled Janssen Sciences Ireland UC
RandomizedCrossoverDouble-blindOther

Summary

The primary objective is to evaluate in a double-blinded (neither physician nor participant knows the treatment that the participant receives), fashion the taste of different JNJ-53718678 oral liquid formulations as compared to the reference formulation (JNJ-53718678, 10 milligram/milliliter oral solution without sweetener/flavor).

Timeline

Start
2015-03-04
Primary completion
2015-04-24
Completion
2015-04-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Rilematovir Other / unclassified 5 ml Oral
Subject Rilematovir Other / unclassified 10 mg/ml Oral

Indications

No indication recorded.